ARCA biopharma ORKA
ARCA biopharma: quarterly report for the quarter ended Mar 31, 2022
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001564590-22-017043
- Document
- 10-Q
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
- Cronos Group CRON public float $380M, Jun 30, 2025
- REGENXBIO RGNX public float $385M, Jun 30, 2025
- Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
- Cryoport CYRX public float $400M, Jun 30, 2025
